Aimmune Therapeutics | search
Click here to view Aimmune Therapeutics news from 60+ newspapers.
Bookmark or Share- Company overview - AimmuneAimmune Therapeutics is a biopharmaceutical company developing and bringing new treatments to people with potentially life-threatening food allergies.
- Aimmune Therapeutics - LinkedInAimmune Therapeutics, Inc., a Nestlé Health Science Company, is a biopharmaceutical company developing and commercializing treatments for potentially life-threatening food allergies.
- Home | AimmuneAimmune Therapeutics, a Nestlé Health Science company, is a biopharmaceutical company that aspires to be a global leader in developing innovative medicines to treat, prevent, and manage food, GI, and metabolic-related diseases for those with few or no treatment options.
- Nestlé completes acquisition of Aimmune TherapeuticsNestlé announced today the successful completion of its acquisition of Aimmune Therapeutics, Inc. (Nasdaq: AIMT). Joining Nestlé Health Science (NHSc) as a stand-alone business unit called Aimmune Therapeutics, a Nestlé Health Science company, it will manage NHSc's global pharmaceutical business.
- Nestlé to acquire Aimmune Therapeutics - Nestlé Health ScienceNestlé and Aimmune Therapeutics, Inc. (Nasdaq: AIMT), a biopharmaceutical company developing and commercializing treatments for potentially life-threatening food allergies (Aimmune), have entered into a definitive agreement pursuant to which Nestlé Health Science (NHSc) would acquire Aimmune.
More
